Alopecia areata - I-Alopecia Areata
☆ AI Dermatology — Free Service
Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
I-Alopecia Areata (Alopecia areata) ibonakala esikhunjeni. Ezimweni ezijwayelekile, ivela ngokuzumayo, inobuso obushelelezi ngokuphelele futhi isayizi ingu-2‑3 cm.
relevance score : -100.0%
ReferencesAlopecia areata yisimo lapho amasosha omzimba ehlasela izimpande zezinwele, okuholela ekulahlekelweni kwezinwele okwesikhashana ngaphandle kwezibazi. Kungavela njengamabala okulahlekelwa izinwele noma kuthinte isikhumba sonke noma umzimba wonke, kuthinta cishe u‑2 % wabantu ngasikhathi sinye empilweni yabo. Icala eliyinhloko libonakala njengokwehluleka kokuvikelwa kwemvelo ezungeze izimpande zezinwele.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata yisimo lapho amasosha omzimba ehlasela khona izinhlayiya zezinwele, okubangela ukuqothuka kwezinwele esikhunjeni sekhanda nezinye izingxenye zomzimba ezinoboya. Kuthinta cishe u-2% wabantu emhlabeni jikelele. Nakuba kungenzeka kunoma iyiphi iminyaka, ivame kakhulu ezinganeni kunabantu abadala (1.92% vs. 1.47%). Abesifazane, ikakhulukazi labo abangaphezu kweminyaka engu-50, bavame ukuba nakho kunabesilisa. Ukusebenzisa ama-corticosteroids ngqo ezindaweni ezithintekile kubonisa imiphumela engcono kunokuwasebenzisa ngokuhlinzwa.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Kukholelwa ukuthi i‑Alopecia areata iyisifo esizimele esihlobene namasosha omzimba ezinqoleni zezinwele. Indlela eyisisekelo ihlanganisa ukwehluleka komzimba ukubona amangqamuzana ezinwele, nokubhujiswa okulandelayo kwe‑immune‑mediated follicle ye‑zinwele.
○ Ukwelashwa – Izidakamizwa ze‑OTC
Abanye abantu abane‑alopecia areata ethambile bayalulama ngaphambi konyaka ngaphandle kokwelashwa. Kodwa-ke, abantu abaningi bahlangabezana nokuphindaphinda kumasayithi angahleliwe ekhanda.
#Hydrocortisone cream
○ Ukwelashwa
Imijovo ye‑intralesional steroid iyindlela yokwelapha ephumelela kakhulu. I‑immunotherapy ingazanywa uma izindawo ezinkulu ze‑scalp zithinteka.
#Triamcinolone intralesional injection
#DPCP immunotherapy